Statements about S.2157: Drug-Price Transparency in Communications Act
One member of Congress have made one statement about this bill.
Date | Member | Party | State / District | Title |
---|---|---|---|---|
May 18, 2018 | Richard J. Durbin | D | IL | Durbin Calls For Transparency From Pharmaceutical Companies in Advertising to Consumers |